Zobrazeno 1 - 10
of 575
pro vyhledávání: '"Magnus, Björkholm"'
Autor:
Frida Schain, Yuliya Leontyeva, Robert Szulkin, Christina Loefgren, Jianming He, Magnus Björkholm
Publikováno v:
HemaSphere, Vol 7, p e6046738 (2023)
Externí odkaz:
https://doaj.org/article/9c93ce6b6103423ba8df62c477146832
Autor:
Zhiqing Fang, Ning Zhang, Xiaotian Yuan, Xiangling Xing, Xiaofeng Li, Xin Qin, Zhengfang Liu, Shiyong Neo, Cheng Liu, Feng Kong, Magnus Björkholm, Yidong Fan, Dawei Xu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-20 (2022)
Abstract Background The ETS transcription factor GABPA has long been thought of as an oncogenic factor and recently suggested as a target for cancer therapy due to its critical effect on telomerase activation, but the role of GABPA in clear cell rena
Externí odkaz:
https://doaj.org/article/71d95ec604714ade8d9cb74a24730485
Autor:
Qing Sun, Junli Liu, Guanghui Cheng, Mingkai Dai, Jiaxi Liu, Zhenqiang Qi, Jingjie Zhao, Wei Li, Feng Kong, Gang Liu, Magnus Björkholm, Dawei Xu
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-11 (2020)
Abstract Background Primary glomerulonephritis (GN) is the leading cause of chronic kidney disease (CKD) and frequently progresses into end stage renal diseases (ESRDs). Shorter leukocyte telomere length (LTL) has been implicated in the CKD susceptib
Externí odkaz:
https://doaj.org/article/3b775d2a94ce4f87a3c00b5666fc49cf
Autor:
Urvi A. Shah, Sæmundur Rögnvaldsson, Andriy Derkach, Magnus Björkholm, Ingemar Turesson, Yael David, Malin Hultcrantz, Carlyn Tan, Hani Hassoun, Neha Korde, Alexander Lesokhin, Sham Mailankody, Sigurður Yngvi Kristinsson, C. Ola Landgren
Publikováno v:
Haematologica, Vol 107, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/37a8902b7e3d4411bdd9816f173c7ff6
Publikováno v:
HemaSphere, Vol 6, Pp 35-35 (2022)
Externí odkaz:
https://doaj.org/article/58b612abb3d049598f48c8bf7e17cfe8
Autor:
Chuanyou Xia, Thale Kristin Olsen, A. Ali Zirakzadeh, Radwa Almamoun, Louise K. Sjöholm, Jenny Dahlström, Jan Sjöberg, Hans-Erik Claesson, John Inge Johnsen, Ola Winqvist, Dawei Xu, Tomas J. Ekström, Magnus Björkholm, Klas Strååt
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
We studied DNA methylation profiles in four different cell populations from a unique constellation of monozygotic triplets in whom two had developed Hodgkin Lymphoma (HL). We detected shared differences in DNA methylation signatures when comparing th
Externí odkaz:
https://doaj.org/article/94f4986070ae4c41a106c7e70907ce02
Autor:
Julien Record, Anton Sendel, Joanna S. Kritikou, Nikolai V. Kuznetsov, Hanna Brauner, Minghui He, Noemi Nagy, Mariana M.S. Oliveira, Elena Griseti, Christoph B. Haase, Jenny Dahlström, Sanjaykumar Boddul, Fredrik Wermeling, Adrian J. Thrasher, Chaohong Liu, John Andersson, Hans-Erik Claesson, Ola Winqvist, Siobhan O. Burns, Magnus Björkholm, Lisa S. Westerberg
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Megakaryoblastic leukemia 1 (MKL1) is a coactivator of serum response factor and together they regulate transcription of actin cytoskeleton genes. MKL1 is associated with hematologic malignancies and immunodeficiency, but its role in B cells is unexp
Externí odkaz:
https://doaj.org/article/d0de30ab92fb41d9b2253b0c0a309db4
Autor:
Sigrun Thorsteinsdottir, Gauti Gislason, Thor Aspelund, Ingigerdur Sverrisdottir, Ola Landgren, Ingemar Turesson, Magnus Björkholm, Sigurður Y. Kristinsson
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
Multiple myeloma causes lytic bone lesions and fractures. The impact of fractures on multiple myeloma (MM) survival is unclear. The aim of this study was to evaluate the effect of fractures on survival in MM using data from MM patients diagnosed in S
Externí odkaz:
https://doaj.org/article/b74be7fbdd77479eba3ac8186976f4a5
Autor:
Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, Ingemar Turesson, Magnus Björkholm, Ola Landgren, Sigurður Yngvi Kristinsson
Publikováno v:
Haematologica, Vol 105, Iss 11 (2020)
Externí odkaz:
https://doaj.org/article/950ffb887ec34d819a9691192ee53721
Autor:
Gudbjörg Jonsdottir, Sigrún H. Lund, Magnus Björkholm, Ingemar Turesson, Malin Hultcrantz, Anna Porwit, Yogesh S. Jethava, Ola Landgren, Sigurdur Y. Kristinsson
Publikováno v:
Blood Advances, Vol 1, Iss 25, Pp 2392-2398 (2017)
Abstract: In the present study, we aimed to evaluate 2 hypotheses. First, we hypothesize that prior malignancy is a proxy for genetic susceptibility that could be a risk factor for subsequent malignancy development in multiple myeloma (MM) patients.
Externí odkaz:
https://doaj.org/article/65a09fa5d9ed4c9283c15badc11b801a